Assessing the Implementation of Universal Test and Treat Services and Health Benefits for HIV Patients in Healthcare Facilities in Nairobi, Kenya

This study examines the implementation of Universal Test and Treat (UTT) for HIV-positive individuals in Kenya, a strategy commonly referred to as Treatment as Prevention (TaSP). UTT is globally recognized for its effectiveness in reducing HIV disease progression, mortality, and transmission. Kenya's high HIV burden accounts for 4% of global infections and a prevalence rate of 5% by the end of 2022, as the country faces significant challenges in fully implementing UTT. The research attempted to respond the question, to what does the implementation of the universal test and treat policy support health benefits for HIV patients? Using the Theory of Change as a framework, the research employed a mixed-methods approach surveying healthcare workers through a cross-sectional descriptive survey design. The findings revealed convergent views on the benefits of UTT therapy, a moderate positive correlation, and a significant relationship between the implementation of UTT and increased health benefits. Implications in practice, programs should enhance the delivery of same-day ART initiation through simplified drug regimens to maximize patient adherence and outcomes. Policies that promote UTT could significantly enhance the quality of care through uninterrupted implementation. The use of mixed methods provided a comprehensive understanding of the impact of test-and-treat services. The study observed that developing tools to address potential limitations in the care cascade is crucial for enhancing the effectiveness of UTT and improving the overall management of HIV in Kenya.